pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,309 catalysts · 4,728 grant · 3,301 8k filing · 2,627 approval · 2,156 device 510k · 1,745 device recall · 1,501 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 17 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-08-08×clear all
type
  • grant4,728
  • 8k filing3,301
  • approval2,627
  • device 510k2,156
  • device recall1,745
  • device pma1,501
device adverse event
1,000
  • recall586
  • earnings584
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Sep 8, 2025

    50
    ›Sep 9, 2025grant340d agoCEDARS-SINAI MEDICAL CENTER — AI-Enhanced Virtual Reality Cognitive Behavioral Therapy to Reduce Anxiety an...Cedars-Sinai Medical Center

    DK grant. $349,160. PI: David Rubin

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIVERSITY OF LOUISVILLE — Cobalamin serves as a key redox-active mediator, protecting Porphyromonas gin...

    GM grant. $273,875. PI: Shirin Ghods

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIVERSITY OF WASHINGTON — Improving fathers' mental health, parenting, and familial engagement through ...University of Washington

    MH grant. $175,403. PI: Anna M Larsen

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoZVELT THERAPEUTICS INC. — Novel Adipose Targeted Gene Therapy for Lipodystrophy

    DK grant. $974,604. PI: Lei Cao

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIVERSITY OF PENNSYLVANIA — Computational methods for taxa-free microbial biomarker discovery and clinica...University of Pennsylvania

    LM grant. $49,538. PI: Anastasia Lucas

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUT SOUTHWESTERN MEDICAL CENTER — Dissecting the tissue-specific role of the NADP(H) phosphatase, Nocturnin

    DK grant. $40,523. PI: Lauren Palluth

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoBETH ISRAEL DEACONESS MEDICAL CENTER — Mapping Mechanosensory Circuits from the Bladder to Barrington's Nucleus

    DK grant. $765,701. PI: Anne (Hanneke) Verstegen

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoMAIA BIOTECHNOLOGY, INC. — Novel Telomere-Targeting Therapy for Advanced Non-Small Cell Lung CancerMAIA Biotechnology, Inc.

    CA grant. $770,168. PI: Victor Zaporojan

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoRAMONA OPTICS, INC. — Rapid inter-procedural 3D scanning of fine-needle aspiration cytology slides ...

    CA grant. $306,872. PI: Mark Harfouche

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoFLORIDA ATLANTIC UNIVERSITY — Estimation of lean body weight in children for drug dose calculation

    HD grant. $152,500. PI: Mike Wells

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoMAYO CLINIC ROCHESTER — Virtual World-based Cardiac Rehabilitation to Promote Data-Powered Cardiovasc...Mayo Clinic

    LM grant. $390,852. PI: LaPrincess C Brewer

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoMICHIGAN STATE UNIVERSITY — A multi-informant investigation of risk and protective factors underlying the...

    DC grant. $668,104. PI: BRIDGET M WALSH

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIVERSITY OF TX MD ANDERSON CAN CTR — Deciphering the role of cancer pain-associated neuronal activity in driving m...

    CA grant. $513,127. PI: Yuan Pan

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoTULANE UNIVERSITY OF LOUISIANA — Efficient Delivery of Optimized Painless Nerve Growth Factors to the Central ...

    NS grant. $624,329. PI: Sina Pourtaheri

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoINDIANA UNIVERSITY INDIANAPOLIS — Coding and Noncoding Molecular Mechanisms of a Bifunctional Gene in Multiple ...

    GM grant. $435,875. PI: Daniel C. Peltier

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — Targeting MBD2 for medulloblastoma therapy

    NS grant. $564,045. PI: ERWIN G. VAN MEIR

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoMAGEE-WOMEN'S RES INST AND FOUNDATION — Conserved and Unique Features Regulating Meiotic Crossover Formation

    GM grant. $919,914. PI: JUDITH YANOWITZ

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIV OF NORTH CAROLINA CHAPEL HILL — The role of the small GTPase Rap1 and environmental cues in the regulation of...

    HL grant. $41,171. PI: Matthew Vander Ploeg

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIVERSITY OF TX MD ANDERSON CAN CTR — Efficient Measurement and Characterization of Genetic Interactions in Cancer ...

    CA grant. $370,173. PI: Traver Hart

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUT SOUTHWESTERN MEDICAL CENTER — Novel approaches to dissect the genetic susceptibilities to celiac disease

    DK grant. $249,000. PI: Xiao-Fei Kong

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoINDIANA UNIVERSITY INDIANAPOLIS — Integrative Multi-Omics Approach to Identify Cell-Type and Brain-Region Speci...

    AA grant. $33,808. PI: Nick Green

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Use of Adjuvant Anti-Obesity Medication to Enhance Surgical Weight LossMetallomix Inc

    DK grant. $177,986. PI: Jason Samuels

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoFIMBRION THERAPEUTICS, INC. — Thiazolino-Pyridone Compounds as Novel Antimycobacterial Drugs for Tuberculosis

    AI grant. $300,000. PI: THOMAS Joseph HANNAN

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoBETH ISRAEL DEACONESS MEDICAL CENTER — Development and Pilot Testing of an Electronic Health Record-based Serious Il...

    AG grant. $191,193. PI: Adrian Haimovich

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoCARE4QOL LLC — Empowering Direct Care Workers with AI-Integrated Wearable Technology to Prev...

    NR grant. $306,817. PI: YUCHI YOUNG

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoMASSACHUSETTS GENERAL HOSPITAL — Capacity Building for the Diagnosis and Treatment of Neuromyelitis Optica usi...Massachusetts General Hospital

    TW grant. $1. PI: Farrah Jasmine Mateen

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoARIZONA STATE UNIVERSITY-TEMPE CAMPUS — Glyco-MAP: a high-throughput multiplexed platform for Glycosylated Mucin Anti...

    CA grant. $183,494. PI: Ji Qiu

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoVIRGINIA POLYTECHNIC INST AND ST UNIV — Leveraging Mexican Millipede Secretions as Neuromodulators

    TW grant. $375,392. PI: Emily Elizabeth Mevers

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — UZ-UCSF CTUUniversity of California San Francisco

    AI grant. $873,804. PI: ZVAVAHERA MIKE CHIRENJE

    full page →nih reporter ↗
    ›Sep 9, 2025grant340d agoUNIVERSITY OF PENNSYLVANIA — Mapping the gene regulatory architecture of pancreatic islet-specific cell ty...University of Pennsylvania

    DK grant. $787,367. PI: Kyle Jeffrie Gaulton

    full page →nih reporter ↗
    ›Sep 10, 2025approval339d agoKOSELUGO (SELUMETINIB SULFATE) — FDA approvalselumetinib sulfate

    Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

    full page →selumetinib sulfate →fda approvals ↗
    ›Sep 10, 2025approval339d agoKOSELUGO (SELUMETINIB) — FDA approvalselumetinib sulfate

    Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

    full page →selumetinib sulfate →fda approvals ↗
    ›Sep 10, 2025approval339d agoOSENVELT (DENOSUMAB-BMWO) — FDA approvalOSENVELT

    Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INJECTION

    full page →OSENVELT →fda approvals ↗
    ›Sep 10, 2025approval339d agoCABOMETYX (CABOZANTINIB S-MALATE) — FDA approvalcabozantinib s-malate

    Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL

    full page →cabozantinib s-malate →fda approvals ↗
    ›Sep 10, 2025recall339d agoBoothwyn Pharmacy LLC recall (Cls II)Novo Nordisk AS

    Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoDermaRite Industries, LLC recall (Cls I)

    PeriGiene, Health Care Antiseptic, (Chloroxylenol 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-198-08 — Reason: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoB BRAUN MEDICAL INC recall (Cls I)B. Braun Medical Inc

    0.9% Sodium Chloride Injection USP, 1000 mL container, Rx only, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7800-09 — Reason: Presence of Particulate Matter. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoDermaRite Industries, LLC recall (Cls I)

    DermaSarra, External Analgesic, (Camphor 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08 — Reason: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoBoothwyn Pharmacy LLC recall (Cls III)

    Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496 — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100-count bottles Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1062-1. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1060-1. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottles, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1056-1. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoDermaRite Industries, LLC recall (Cls I)

    DermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E (Chloroxylenol 0.2%), packaged in a) 800 ml (27 fl. oz.) bag-n-box (NDC 61924-092-27) and b) 1000ml (34 fl. oz.) bag-n-box (NDC 61924-092-34) , DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. — Reason: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    Sulfamethoxazole and Trimethoprim Tablets, USP 800mg/160mg, Double Strength, Rx Only, Packaged as a) 100-count bottle, NDC 65162-272-10; b) 500-count bottle, NDC 65162-272-50; Manufactured by: Amneal Pharmaceuticals, Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoDermaRite Industries, LLC recall (Cls I)

    KleenFoam, Antimicrobial Foam Soap with Aloe Vera, (Chloroxylenol 0.5%) 34 FL OZ (1000 mL) per cartridge, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-093-34 — Reason: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1058-1. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoBoothwyn Pharmacy LLC recall (Cls II)Novo Nordisk AS

    Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoB BRAUN MEDICAL INC recall (Cls I)B. Braun Medical Inc

    Lactated Ringers's Injection USP, 1000 mL container, Rx only, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7750-07 — Reason: Presence of Particulate Matter — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoIMMUNOCORE, LLC recall (Cls II)Immunocore Holdings plc

    KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kingdom, For: Immunocore Commercial LLC, 181 Washington St, Conshohocken, PA, 19428, Product of Denmark NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026 — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall339d agoBoothwyn Pharmacy LLC recall (Cls II)Novo Nordisk AS

    Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ← prev
    page 22 of 367
    next →
    $MAIA
    $AZN157.24-0.79%
    $AZN157.24-0.79%
    $AMRX17.27-2.21%
    $AMRX17.27-2.21%
    $AMRX17.27-2.21%
    $AMRX17.27-2.21%
    $AMRX17.27-2.21%
    $IMCR34.20-1.55%
    $EXEL50.61+0.46%